DIOVAN HCT NEWS HIGHLIGHTS Media Articles Related to Diovan HCT (Valsartan / Hydrochlorothiazide)
International Medical Team Announces Patient Results In Adult Stem Cell Clinical Study For Pulmonary Hypertension
Source: Cardiovascular / Cardiology News From Medical News Today [2008.11.27]
Why Does It Take So Long For A Correct Diagnosis Of Pulmonary Hypertension?
Source: Respiratory / Asthma News From Medical News Today [2008.11.26]
Hypertension May Hit Black Males Earlier
Source: MedicineNet Exercise and Activity Specialty [2008.11.25]
Office Blood Pressure Measurement Useless in Patients with Resistant Hypertension
Source: MedPage Today Cardiovascular [2008.11.24]
Hypertension Develops Early, Silently, In African-American Men
Source: Hypertension News From Medical News Today [2008.11.18]
Published Studies Related to Diovan HCT (Valsartan / Hydrochlorothiazide)
Randomized, Double-blinded Trial Evaluation of Valsartan/Hydrochlorothiazide Combination Therapy in Mild to Moderate Essential Hypertension in North-east China. [2008.07]
Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy. [2008.06]
Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy. [2008.01.24]
[Therapeutic efficacy of valsartan and valsartan/HCTZ in mild to moderate hypertensive patients] [2007.08]
Aliskiren, an orally effective Renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. [2007.01]
Clinical Trials Related to Diovan HCT (Valsartan / Hydrochlorothiazide)
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide. [Active, not recruiting]
A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan. [Completed]
To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers [Completed]
8-Week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension [Completed]
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects. [Completed]
|
